|Company name||MGT Capital Investments|
NEW YORK, September 5, 2019 – Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of MGT Capital Investments (NYSE: MGTI) on behalf of long-term stockholders of MGT Capital Investments securities.
Bragar Eagel and Squire is investigating certain officers and directors of MGT Capital Investments following a class action complaint that was filed against MGT Capital on October 9, 2018.
The complaint alleges that throughout the class period, defendants made materially false and misleading statements regarding the company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) defendants were engaged in an illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price; (2) the scheme defendants had a history of engaging in illegal conduct in connection with the purchase and sale of securities; (3) the scheme defendants were a “group”, pursuant to Section 13 of the Exchange Act; (4) the scheme defendants exercised control over the Company; (5) the Company’s acquisition of D-Vasive Inc. was part of defendants’ illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price; (6) defendants’ illicit scheme caused MGT Capital to make false and misleading statements, which would result in governmental and regulatory scrutiny; (7) the scheme would result in the delisting of MGT Capital’s stock from NYSE MKT; and (8) as a result, defendants’ statements about MGT Capital’s business and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you are a long-term stockholder of MGT Capital Investments securities, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.